SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-19-001599
Filing Date
2019-02-13
Accepted
2019-02-13 14:08:25
Documents
14

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1608927
2 filename2.htm EX-10.9 527267
3 GRAPHIC g693812g00x53.jpg GRAPHIC 55149
4 GRAPHIC g693812g0211194013978.jpg GRAPHIC 3310
5 GRAPHIC g693812g05v96.jpg GRAPHIC 58995
6 GRAPHIC g693812g30i04.jpg GRAPHIC 267912
7 GRAPHIC g693812g30r17.jpg GRAPHIC 285472
8 GRAPHIC g693812g45l49.jpg GRAPHIC 90173
9 GRAPHIC g693812g56b21.jpg GRAPHIC 277963
10 GRAPHIC g693812g69m46.jpg GRAPHIC 53002
11 GRAPHIC g693812g80b01.jpg GRAPHIC 54882
12 GRAPHIC g693812g82h55.jpg GRAPHIC 90772
13 GRAPHIC g693812g89m33.jpg GRAPHIC 83407
14 GRAPHIC g693812g95b38.jpg GRAPHIC 264551
  Complete submission text file 0000950123-19-001599.txt   4319537
Mailing Address 2330 INWOOD RD. SUITE 226 DALLAS TX 75235
Business Address 2330 INWOOD RD. SUITE 226 DALLAS TX 75235 972-629-4100
Peloton Therapeutics, Inc. (Filer) CIK: 0001525145 (see all company filings)

IRS No.: 273349428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-02506 | Film No.: 19596157
SIC: 2836 Biological Products, (No Diagnostic Substances)